Archives
Mislabeled Bottles Trigger Recall of the ADHD Drug Zenzedi
No serious injuries related to the medication mix-up have been reported
Strategies Needed to Improve Delivery of Alzheimer Disease-Modifying Therapies
Models that enable primary care practitioners to diagnose and evaluate patients for treatment eligibility would have biggest impact on wait times
Microbial Contamination Prompts Recall of Robitussin Honey Cough Syrup
Manufacturer says that no illnesses in customers using the product have yet been reported
Amid Continuing Shortage, Red Cross Repeats Call for Blood Donors
The United States has the lowest number of people giving blood observed over the past 20 years
FDA: CAR T-Cell Therapies May Increase Risk for Rare Secondary Cancers
Twenty-five reports of rare blood cancers in patients who had received CAR T-cell therapy prompted agency's warning
Diagnostic Accuracy High in Emergency Departments
Only about 5.7 percent of patients receive incorrect diagnosis, with about 2.0 percent suffering adverse events as a result
FDA Says Marijuana Should Be Reclassified as Less Risky Drug
Currently, cannabis is classified as a Schedule I controlled substance, a category that includes heroin and LSD
CDC: Although Season Not Over, Flu Activity Is Slowing Down
So far this season, the flu has caused at least 14 million illnesses, 150,000 hospitalizations, and 9,400 deaths
Salmonella Risk Prompts Quaker Oats to Widen Granola Bar, Cereal Recall
No cases of Salmonella illness have yet been reported linked to the recalled products
Psychologists’ Group Issues First Guidelines on Teens’ Use of Social Media
There are both benefits and harms involved in social media use, and the report authors sought a balanced approach
